Illumina turns down Roche's $5.7B bid

02/7/2012 | Reuters

Illumina's board rejected Roche's $5.7 billion takeover bid and advised shareholders not to tender their shares to Roche. Illumina said the bid undervalued the gene-sequencing firm. Roche called the offer "full and fair" and said it was ready to enter discussions with Illumina.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC